These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21663507)

  • 81. Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Shimizu-Kohno K; Kato S; Tomita A; Kinoshita T; Nakamura S; Asano N
    Pathol Int; 2015 Dec; 65(12):652-60. PubMed ID: 26538151
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Long-term follow-up of 2 patients treated with
    Golstein SC; Muylle K; Vercruyssen M; Spilleboudt C; de Wind A; Bron D
    Eur J Haematol; 2018 Sep; 101(3):415-417. PubMed ID: 29719928
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.
    Advani RH; Horning SJ; Hoppe RT; Daadi S; Allen J; Natkunam Y; Bartlett NL
    J Clin Oncol; 2014 Mar; 32(9):912-8. PubMed ID: 24516013
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.
    Molin D; Linderoth J; Wahlin BE
    Br J Haematol; 2017 May; 177(3):449-456. PubMed ID: 28233899
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy.
    Picardi M; Zeppa P; Ciancia G; Pettinato G; Grimaldi F; Fabbricini R; Mainolfi C; Pane F
    Leuk Lymphoma; 2011 Nov; 52(11):2082-9. PubMed ID: 21663508
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nodular lymphocyte-predominant hodgkin lymphoma.
    Tsai HK; Mauch PM
    Semin Radiat Oncol; 2007 Jul; 17(3):184-9. PubMed ID: 17591565
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
    Bhargava P; Pantanowitz L; Pinkus GS; Pinkus JL; Paessler ME; Roullet M; Gautam S; Bagg A; Kadin ME
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):16-23. PubMed ID: 19550297
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.
    Hartmann S; Plütschow A; Mottok A; Bernd HW; Feller AC; Ott G; Cogliatti S; Fend F; Quintanilla-Martinez L; Stein H; Klapper W; Möller P; Rosenwald A; Engert A; Hansmann ML; Eichenauer DA
    Am J Hematol; 2019 Nov; 94(11):1208-1213. PubMed ID: 31396979
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma.
    Odei B; Boothe D; Frandsen J; Poppe MM; Gaffney DK
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):819-824. PubMed ID: 29051078
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
    Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
    Ali A; Sayed H; Farrag A; El-Sayed M
    Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
    Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
    Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Nodular lymphocyte-predominant Hodgkin's lymphoma: Principles of diagnosis and treatment].
    Moiseeva TN; Al-Radi LS; Kovrigina AM; Goryacheva SR; Julakyan UL; Margolin OV; Skidan NI; Tseytlina MA; Kravchenko SK
    Ter Arkh; 2015; 87(11):78-83. PubMed ID: 26821421
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma.
    Vassilakopoulos TP; Angelopoulou MK; Pangalis GA
    Leuk Lymphoma; 2006 Aug; 47(8):1450-1. PubMed ID: 16966251
    [No Abstract]   [Full Text] [Related]  

  • 97. Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
    Hall GW; Katzilakis N; Pinkerton CR; Nicolin G; Ashley S; McCarthy K; Daw S; Hewitt M; Wallace WH; Shankar A
    Br J Haematol; 2007 Sep; 138(6):761-8. PubMed ID: 17760808
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma.
    Maraldo MV; Aznar MC; Vogelius IR; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1057-65. PubMed ID: 23200817
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience.
    Gemici A; Aydogdu I; Terzi H; Sencan M; Aslan A; Kaya AH; Dal MS; Akay MO; Dogu MH; Ayyildiz O; Sahin F; Cagliyan GA; Yilmaz M; Gokgoz Z; Bilen Y; Demir C; Sevindik OG; Korkmaz S; Eser B; Altuntas F;
    Hematol Oncol; 2018 Feb; 36(1):116-120. PubMed ID: 28707314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.